Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization

Cell

Volumn 108, Issue 2, 2002, Pages 271-282

  He, Li ^a   Fong, Jamie ^a   Von Zastrow, Mark ^c   Whistler, Jennifer L ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MU OPIATE RECEPTOR; OPIATE DERIVATIVE; RECEPTOR;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERANCE; ENDOCYTOSIS; HUMAN; HUMAN CELL; LONG TERM CARE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ANIMALIA;

EID: 0037169345     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00613-X     Document Type: Article

References (57)

1. Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C-like and MOR-1-like immunoreactivity: Evidence for region-specific processing
2. Characteristics of mu and delta opioid binding sites in striatal slices of morphine-tolerant and -dependent mice
3. Intrathecal coadministration of serotonin and morphine differentially modulates the tail-flick reflex of intact and spinal rats
4. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)
5. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells
6. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma
7. mu-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance
8. Differential opioid agonist regulation of the mouse mu opioid receptor
9. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence
10. Increased probability of GABA release during withdrawal from morphine
11. Chronic morphine increases mu-opiate receptor binding in rat brain: A quantitative autoradiographic study
12. Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal
13. Cellular mechanisms of opioid tolerance: Studies in single brain neurons
14. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1
15. Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering mu-opioid receptor sensitivity
16. The effect of intrinsic efficacy on opioid tolerance
17. Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitization and signaling
18. Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal
19. Modulation of mu opioid binding sites in rat spinal cord by chronic intrathecal infusion of morphine and naloxone: A quantitative autoradiography approach
20. Opioid Peptides: Introduction
21. Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: Association with an up-regulation of the cyclic AMP pathway
22. G-protein-coupled receptor heterodimerization modulates receptor function
23. Oligomerization of opioid receptors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation
24. Morphine activates opioid receptors without causing their rapid internalization
25. mu-Opioid receptor internalization: Opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain
26. Oligomerization of dopamine and serotonin receptors
27. Mechanisms of beta-adrenergic receptor desensitization and resensitization
28. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: Effects of naltrindole and its benzofuran analog (NTB)
29. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene
30. A locus and mechanisms of action for associative morphine tolerance
31. NeuN, a neuronal specific nuclear protein in vertebrates
32. Under siege: The brain on opiates
33. Molecular basis of long-term plasticity underlying addiction
34. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors
35. A rapid and simple method for the quantitative determination of tolerance development to opiates in the guinea-pig ileum in vitro
36. Upregulation of the opioid receptor complex by the chronic administration of morphine: A biochemical marker related to the development of tolerance and dependence
37. Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: Decrease in activity after chronic morphine treatment
38. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance
39. Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain
40. Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain
41. Selectivity in the control of opiate receptor density in the animal and in cultured fetal brain cells
42. mu-Opioid receptor downregulation contributes to opioid tolerance in vivo
43. Agonist-selective endocytosis of mu opioid receptor by neurons in vivo
44. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion
45. Immunohistochemical evidence of down-regulation of mu-opioid receptor after chronic PL-017 in rats
46. Inhibition of morphine tolerance and dependence by diazepam and its relation to micro-opioid receptors in the rat brain and spinal cord
47. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function
48. Postsynaptic signaling via the mu-opioid receptor: Responses of dorsal horn neurons to exogenous opioids and noxious stimulation
49. Opioid receptor endocytosis and activation of MAP kinase pathway
50. Selective changes in mu opioid receptor properties induced by chronic morphine exposure
51. Morphine-activated opioid receptors elude desensitization by beta-arrestin
52. Functional dissociation of mu opioid receptor signaling and endocytosis: Implications for the biology of tolerance and addiction
53. Cellular and synaptic adaptations mediating opioid dependence
54. Spinal systems and pain processing: Development of novel analgesic drugs with mechanistically defined models
55. Chronic catheterization of the spinal subarachnoid space
56. Simple catheter preparation for permitting bolus intrathecal administration during chronic intrathecal infusion
57. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness